Literature DB >> 2398609

Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives.

W P McKinney1, D L Schiedermayer, N Lurie, D E Simpson, J L Goodman, E C Rich.   

Abstract

We surveyed faculty and residents from seven hospitals affiliated with three academic internal medicine training programs about their perceptions of the informational and service benefits vs the risks of ethical compromise involved in interactions with pharmaceutical sales representatives. Questionnaires were returned by 467 (81%) of 575 physicians surveyed. Residents and faculty generally had somewhat negative attitudes toward the educational and informational value of detailing activities at their institutions but indicated that representatives supported important conferences and speakers. Residents were more likely than faculty to perceive contacts with sales representatives as potentially influencing physician decision making. Sixty-seven percent of faculty and 77% of residents indicated that physicians could be compromised by accepting gifts. More than half of the physicians who suggested that such compromise was possible indicated that acceptance of gifts worth more than +100 from drug companies would be likely to compromise a physician's independence and objectivity. A majority of both faculty and house staff favored eliminating presentations by pharmaceutical representatives at their hospitals. Only 10% thought they had had sufficient training during medical school and residency regarding professional interaction with sales representatives.

Mesh:

Year:  1990        PMID: 2398609

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  24 in total

1.  Pharmaceutical advertising revenue and physician organizations: how much is too much?

Authors:  P A Glassman; J Hunter-Hayes; T Nakamura
Journal:  West J Med       Date:  1999-10

2.  Accepting commercial sponsorship. Disclosure helps--but is not a panacea.

Authors:  L A Bero
Journal:  BMJ       Date:  1999-09-11

3.  The HEC and conflicts of interest in the health care environment.

Authors:  J P Orlowski
Journal:  HEC Forum       Date:  1994-01

4.  Teaching appropriate interactions with pharmaceutical company representatives: the impact of an innovative workshop on student attitudes.

Authors:  James L Wofford; Christopher A Ohl
Journal:  BMC Med Educ       Date:  2005-02-08       Impact factor: 2.463

Review 5.  Interactions between pharmaceutical representatives and doctors in training. A thematic review.

Authors:  Daniella A Zipkin; Michael A Steinman
Journal:  J Gen Intern Med       Date:  2005-08       Impact factor: 5.128

6.  Interactions of doctors with the pharmaceutical industry.

Authors:  M A Morgan; J Dana; G Loewenstein; S Zinberg; J Schulkin
Journal:  J Med Ethics       Date:  2006-10       Impact factor: 2.903

7.  Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks.

Authors:  B Hodges
Journal:  CMAJ       Date:  1995-09-01       Impact factor: 8.262

Review 8.  Bioethics for clinicians: 17. Conflict of interest in research, education and patient care.

Authors:  T Lemmens; P A Singer
Journal:  CMAJ       Date:  1998-10-20       Impact factor: 8.262

9.  Ethical and Professional Challenges Encountered by Laboratory Genetic Counselors.

Authors:  Daniel Groepper; Patricia McCarthy Veach; Bonnie S LeRoy; Matthew Bower
Journal:  J Genet Couns       Date:  2014-11-16       Impact factor: 2.537

10.  Japanese practicing physicians' relationships with pharmaceutical representatives: a national survey.

Authors:  Sayaka Saito; Kei Mukohara; Seiji Bito
Journal:  PLoS One       Date:  2010-08-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.